<DOC>
	<DOCNO>NCT01819857</DOCNO>
	<brief_summary>For many year droperidol use prophylaxis therapy PONV . Information provoke disorder cardiac ventricular rhythm reduce popularity . However data n't base solid examination confirm torsadogenic action droperidol . It known droperidol prolongs time repolarisation , n't data confirm impact transmural dispersion repolarisation . Only estimation action one time allow define sure arrhythmogenic role droperidol . The aim study answer question : 6 . Does droperidol make significant prolongation heart repolarisation , express correct QT interval ? 1 . Does droperidol cause increase transmural dispersion repolarisation ? 2 . Does possible torsadogenic act droperidol depend dose drug ? 3 . Does ondansetron cause change electrical heart function , suggest possibility induce TdP tachycardia ? 4 . What torsadogenic potential droperidol ondansetron use prophylaxis PONV people suffer cardiovascular disease ?</brief_summary>
	<brief_title>Droperidol Cardiac Repolarization</brief_title>
	<detailed_description />
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Droperidol</mesh_term>
	<criteria>age 1860 year sex : male ASA score I II treatment drug influence cardiac repolarization coronary artery disease heart insufficiency NYHA &gt; 1 serum electrolyte disturbance hypersensitivity droperidol and/or ondansetron</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>